Iteos Therapeutics Inc expected to post earnings of $1.28 a share - Earnings Preview

iTeos Therapeutics

18/03/2022 20:08

* Iteos Therapeutics Inc  ITOS.OQ   ITOS.O  is expected
to show a
rise in quarterly revenue when it reports  results on March 22
(estimated). 
    * The Watertown Massachusetts-based  company is expected to
report
revenue of $85.458 million, according to the mean estimate from
5 analysts, based on Refinitiv data.  
    * ​Refinitiv's mean analyst estimate for Iteos Therapeutics
Inc is
for earnings of $1.28 per share. For the same quarter last year,
the company reported a loss of 43 cents per share.
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 5 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Iteos
Therapeutics Inc is $52​, above​ its last closing price
of $35.89. ​​​
    * Previous quarterly performance (using preferred earnings
measure
in US dollars). ​

 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Sep. 30 2021  6.09        4.95       1.86      Missed  -62.4
 Jun. 30 2021  -0.45       -0.41      -0.75     Missed  -81.2
 Mar. 31 2021  -0.48       -0.48      -0.39     Beat    18.4​
 Dec. 31 2020              -0.42      -0.43     Missed  -1.8
 ​​Sep.        -0.36       -0.36      -0.48     Missed  -31.9
 30 2020                                                
 Jun. 30 2020  -0.47       -0.47      -29.49    Missed  -6,208
                                                        ​
 This summary was machine generated March 18 at 20:08 GMT.  All
figures in US dollars  unless otherwise stated